Exemption number e2019001.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of cerebrovascular accident, thrombosis, weakness and air embolism as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The investigation determined the reported paresis appears to be related to the cerebral infarction.However, a conclusive cause for the cerebral infarction, thrombus, and air embolism cannot be determined.It is possible that patient conditions contributed to cerebral infarction, thrombus, and air embolism; however, this cannot be confirmed.There is no indication of a product issue with respect to manufacture, design or labeling.
|
This is filed to report cerebral infarction.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 3.One mitraclip was implanted, reducing mr to <1.On (b)(6) 2019, after the patient woke from anesthesia, a cerebral infarction was confirmed with ct imaging.Paresis in the left lower limb was noted.The in the physician's opinion, a thrombus and an air embolism that occurred during the procedure could be the cause of the infarction.However, the thrombus and air embolism were not confirmed.Heparin was continued and edaravone was administered as treatment for the cerebral infarction.The paresis is almost resolved, however a light paresis of the left lower limb is still present.There was no clinically significant delay in the procedure.Hospitalization was prolonged.No additional information was provided.
|